Kades & Cheifetz LLC Amgen Inc Transaction History
Kades & Cheifetz LLC
- $175 Billion
- Q3 2024
A detailed history of Kades & Cheifetz LLC transactions in Amgen Inc stock. As of the latest transaction made, Kades & Cheifetz LLC holds 1,052 shares of AMGN stock, worth $333,988. This represents 0.19% of its overall portfolio holdings.
Number of Shares
1,052
Previous 1,017
3.44%
Holding current value
$333,988
Previous $318 Million
6.62%
% of portfolio
0.19%
Previous 0.2%
Shares
5 transactions
Others Institutions Holding AMGN
# of Institutions
3,056Shares Held
409MCall Options Held
7.19MPut Options Held
6.26M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.5 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.2 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.59 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.56 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $170B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...